2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Market research budgets rise an average 229% once compounds reach phase II clinical testing, according to a new study from pharmaceutical intelligence firm Cutting Edge Information.
On average, brand teams spend slightly more than $575,000 on phase II market research activities, up from $207,273 for phase I. The spending increase is important because market research data often informs the decision whether to shift to phase III testing.
The new study, "Pharmaceutical Market Research: Decision Support for Brand Growth," reveals that large pharmaceutical products routinely spend more than $1.0 million during phase II …
No comments:
Post a Comment